JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Benny Weksler
Manjit Bains
Michael Burt
Nael Martini
Valerie Rusch
Robert Ginsberg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weksler, B.
Right arrow Articles by Ginsberg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weksler, B.
Right arrow Articles by Ginsberg, R.

J Thorac Cardiovasc Surg 1997;114:500-501
© 1997 Mosby, Inc.


BRIEF COMMUNICATIONS

RESECTION OF LUNG CANCER INVADING THE DIAPHRAGM

Benny Weksler , MD, Manjit Bains , MD, Michael Burt , MD, PhD, Robert Downey , MD, Nael Martini , MD, Valerie Rusch , MD, Robert Ginsberg , MD


New York, N.Y.

From the Division of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center New York, N. Y.

Received for publication March 4, 1997; accepted for publication March 17, 1977. Address for reprints: Robert Ginsberg, MD, Memorial SloanKettering Cancer Center, Division of Thoracic Surgery, 1275 York Ave., New York, NY 10021.

Each year, stage III non-small-cell lung cancer (NSCLC) is diagnosed in approximately 30,000 patients. Locally advanced NSCLC (stage IIIA) includes a group of biologically diverse tumors with subgroups of truly locally advanced disease—T3 tumors and advanced locoregional disease with the presence of N2 disease. The prognosis of patients with a diagnosis of stage III lung cancer is mainly dependent on the status of the mediastinal nodes. Good long-term results are achieved in patients with No disease, whereas patients with N2 disease are poor candidates for resection as a primary treatment.Go Go Go 1-3 Information is not available on results of surgical treatment of patients with stage III disease and tumors involving the diaphragm.

Patients and methods.

From January 31, 1974, to August 17, 1995, a total of 4668 patients underwent exploration for resection of NSCLC at Memorial Hospital. By analyzing our database we identified eight patients (0.17%) who had exploratory thoracotomy for resection of NSCLC invading the diaphragm. The medical records of these eight patients were retrospectively analyzed. Data are reported as mean ± standard deviation. Survival data are reported as mean and 95% confidence interval (CI) for the mean. The Kaplan-Meier method was used to calculate actuarial survival.

Results.

The demographics of these eight patients are shown in GoTable I. The mean age at diagnosis was 65.8 ± 10.2 years, ranging from 52.6 to 82.4 years. The most common symptoms were cough in four patients, hemoptysis in two patients, and the chest pain in one patient. One patient had clubbing of the fingers. Three patients were free of symptoms. All patients smoked. The mean time from first symptoms to referral for treatment was 25.1 ± 16.6 weeks, ranging from 5.3 to 49 weeks. The histologic diagnosis was made by bronchoscopic examination in four patients and by fluoroscopic guided needle biopsy in two. In two patients the diagnosis was made in the operating room. Four tumors were on the right side and four on the left side. Two patients underwent mediastinoscopy, both studies yielding negative results. The other six did not undergo preoperative mediastinoscopy. Among the eight patients, diaphragmatic invasion was not suspected at exploration in six and it was the suspected before the operation in one; the eighth patient was treated by exploration, immediate closure of the incision, subsequent chemotherapy and radiation therapy, and then complete resection. Surgical treatment included wedge resuction in one patient, lobectomy in four, bilobectomy in one, and right pneumonectomy in one. One patient was deemed to have unresectable disease and received radiotherapy via after loading catheters. The diaphragm was resected en bloc with the tumor in seven patients, and all but one under went primary closure of the diaphragm; one patient had reconstruction with polytetrafluoroethylene mesh.


View this table:
[in this window]
[in a new window]
 
Table I. Demographics
 
Seven patients had squamous cell carcinoma and one patient had adenosquamous carcinoma. The tumor pathologically invaded the diaphragmatic musclc in all resected specimens. Final pathologic stage was T3 No in four patients and T3 N2 in four patients. All patients survived the operation and were discharged from the hospital. Complications were minor. Mean hospital stay was 8.6 ± 9.4 days, ranging from 4 to 32 days. Follow-up data were complete on all patients. Survival was 52.8 weeks (95% CI 12.4 to 93.1 weeks). Of the four patients with N2 disease, all died of recurrent disease with a mean survival of 92.1 weeks (95% CI 28.4 to 155.8 weeks). Of patients with No disease, one is alive 69.4 weeks after the operation and the other three died of causes unrelated to their disease. In four patients who had N2 disease, the recurrent disease occurred 53.6 ± 75.0 weeks after the operation. The site of first recurrence was the brain in three patients and axillary node in one patient. Survival after recurrence was only 27.4 ± 34.1 weeks.

Discussion.

To our knowledge, this is the first report in the English literature on patients undergoing surgical resection for diaphragmatic invasion. It is possible that the reason for the rarity of this condition is that many patients have late disease in the form of T4 tumors with malignant pleural effusion when first referred for treatment. Because resectable lung cancer invading the diaphragm is a rare entity (only 0.17% of all patients having exploratory operations), very little information is available on the proper management strategy. In our series, diaphragmatic invasion was not suspected before the operation. Most patients had symptoms related to lung cancer but none had symptoms that could point the surgeon to the diaphragm (shoulder pain, for example). Technically, in six of seven patients the diaphragm was reconstructed by primary repair; only one patient (patient 5) required mesh reconstruction. It is interesting that practically all patients had squamous cell carcinoma, whereas one would expect that adenocarcinoma would comprise at least half of all specimens. Most patients underwent some form of pulmonary resection, although one patient could not withstand resection. This patient was treated with radiation and chemotherapy and survived 28 weeks. Four patients had N2 disease, discovered during exploration, and all died of distant disease. Detection of N2 disease becomes of paramount importance in view of recent data suggesting that preoperative chemotherapy improves survival in such patients,Go Go 4,5 Ourfollow-up on patients without involved mediastinal nodes is disappointing, because three of four patients died relatively soon after the operation of causes unrelated to their lung cancer. To our knowledge, none had evidence of disease at the time of death. Postoperative follow-up in the single patient who is free of disease is only 69.4 weeks.

In summary, resectable tumors invading the diaphragm are rare. Careful evaluation of the mediastinum with mediastinoscopy is important to detect N2 disease and select those patients for preoperative chemotherapy. Most tumors found to invade the diaphragm during surgery can be resected and the diaphragm closed primarily. The survival benefit of resecting the tumor in patients with diaphragmatic invasion is not clear. Because this is an unusual entity, it may be difficult to determine whether surgery is the adequate treatment modality. We believe that in patients without involved mediastinal nodes and in good general condition, diaphragmatic invasion should be treated by resecting the tumor en bloc with the diaphragm.

References

  1. McCaughan BC, Martini N, Bains MS, McCormack PM. Chest wall invasion in carcinoma of the lung; therapeutic and prognostic implications. J Thorac Cardiovasc Surg 1985;89;836-41.
  2. Martini N, Flehinger BJ, Zaman MB, Beattie EJ Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198;386-97.
  3. Goldstraw P, Mannam GC, Kaplan DK, Michail P. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J. Thorac Cardiovasc Surg 1994;107;19-28.
  4. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer [see comments]. N Engl J Med 1994;330:153-8. [Abstract/Free Full Text]
  5. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer [see comments]. J Natl Cancer Inst 1994;86:673-80.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Bini, M. Grazia, F. Petrella, and R. Bazzocchi
Pulmonary infiltration from retroperitoneal carcinoma requiring diaphragm, chest wall and lung resection after thoracoabdominal access
Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 168 - 170.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. J. Scott, J. Howington, and B. Movsas
Treatment of Stage II Non-small Cell Lung Cancer
Chest, January 1, 2003; 123(1_suppl): 188S - 201S.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Yokoi
Reply
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1225 - 1226.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Riquet and L. Lang-Lazdunski
Results of surgical treatment of lung cancer involving the diaphragm
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1224 - 1225.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Yokoi, R. Tsuchiya, T. Mori, K. Nagai, T. Furukawa, S. Fujimura, K. Nakagawa, and Y. Ichinose
Results of surgical treatment of lung cancer involving the diaphragm
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 799 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Riquet, H. Porte, A. Chapelier, P.-Y. Brichon, A. Bernard, A. Dujon, M. Dahan, P. Bonette, R. Guidicelli, R. Jancovici, et al.
Resection of lung cancer invading the diaphragm
J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 417 - 418.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Rocco, E. A. Rendina, A. Meroni, F. Venuta, C. Della Pona, T. De Giacomo, M. Robustellini, G. Rossi, F. Massera, G. Vertemati, et al.
Prognostic factors after surgical treatment of lung cancer invading the diaphragm
Ann. Thorac. Surg., December 1, 1999; 68(6): 2065 - 2068.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. A. Adebonojo, A. N. Bowser, D. M. Moritz, and P. C. Corcoran
Impact of Revised Stage Classification of Lung Cancer on Survival: A Military Experience
Chest, June 1, 1999; 115(6): 1507 - 1513.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Inoue, M. Sato, S. Fujimura, A. Sakurada, S. Takahashi, K. Usuda, T. Kondo, T. Tanita, M. Handa, Y. Saito, et al.
Prognostic assessment of 1310 patients with non-small-cell lungcancer who underwent complete resection from 1980 to 1993
J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 407 - 411.
[Abstract] [Full Text]


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Benny Weksler
Manjit Bains
Michael Burt
Nael Martini
Valerie Rusch
Robert Ginsberg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weksler, B.
Right arrow Articles by Ginsberg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weksler, B.
Right arrow Articles by Ginsberg, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS